CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)

CUSIP: 230770109

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common stock
Shares outstanding
15,075,924
Total 13F shares
5,416,164
Share change
+176,190
Total reported value
$27,128,000
Put/Call ratio
104%
Price per share
$5.00
Number of holders
38
Value change
+$892,622
Number of buys
11
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARIEL INVESTMENTS, LLC
13F
Company
13%
1,992,613
$8,967,000 30 Jun 2016
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.6%
850,507
$3,827,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
2.5%
381,531
$1,717,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
2%
297,223
$1,337,000 30 Jun 2016
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
277,300
$1,248,000 30 Jun 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
1.8%
275,974
$1,242,000 30 Jun 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.6%
235,300
$1,059,000 30 Jun 2016
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.9%
136,201
$613,000 30 Jun 2016
13F
Stonepine Capital Management, LLC
13F
Company
0.85%
128,798
$580,000 30 Jun 2016
13F
BARD ASSOCIATES INC
13F
Company
0.63%
94,315
$424,000 30 Jun 2016
13F
EAGLE GLOBAL ADVISORS LLC
13F
Company
0.55%
83,535
$376,000 30 Jun 2016
13F
UNITED CAPITAL FINANCIAL ADVISORS, LLC
13F
Company
0.48%
72,826
$364,000 30 Jun 2016
13F
Invesco Ltd.
13F
Company
0.49%
74,190
$334,000 30 Jun 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.36%
53,800
$242,000 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.32%
48,121
$216,000 30 Jun 2016
13F
MORGAN STANLEY
13F
Company
0.25%
37,513
$169,000 30 Jun 2016
13F
Spark Investment Management LLC
13F
Company
0.22%
33,900
$152,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
0.21%
31,842
$143,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
0.17%
25,478
$115,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
0.14%
21,334
$96,000 30 Jun 2016
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.09%
14,050
$63,000 30 Jun 2016
13F
CITADEL ADVISORS LLC
13F
Company
0.09%
12,895
$58,000 30 Jun 2016
13F
DELTA ASSET MANAGEMENT LLC/TN
13F
Company
0.08%
12,000
$55,000 30 Jun 2016
13F
JW Asset Management, LLC
13F
Company
0.07%
10,939
$49,000 30 Jun 2016
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.07%
10,000
$45,000 30 Jun 2016
13F
Emerald Acquisition Ltd.
13F
Company
0.03%
5,198
$23,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.03%
4,500
$20,000 30 Jun 2016
13F
Nationwide Fund Advisors
13F
Company
0.03%
3,851
$17,000 30 Jun 2016
13F
Oakworth Capital, Inc.
13F
Company
0.02%
3,052
$14,000 30 Jun 2016
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.01%
2,000
$9,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.01%
1,900
$9,000 30 Jun 2016
13F
CITIGROUP INC
13F
Company
0.01%
1,200
$5,000 30 Jun 2016
13F
MSI Financial Services Inc
13F
Company
0.01%
1,000
$5,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
1,139
$4,000 30 Jun 2016
13F
Walleye Trading LLC
13F
Company
0.01%
911
$4,000 30 Jun 2016
13F
UBS Group AG
13F
Company
0.01%
896
$4,000 30 Jun 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
894
$4,000 30 Jun 2016
13F
USA MUTUALS ADVISORS, INC.
13F
Company
0%
738
$3,000 30 Jun 2016
13F
MUFG Americas Holdings Corp
13F
Company
0%
710
$3,000 30 Jun 2016
13F
SEI INVESTMENTS CO
13F
Company
0%
254
$1,000 30 Jun 2016
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0%
200
$1,000 30 Jun 2016
13F

Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q3 2016

As of 30 Sep 2016, CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,416,164 shares. The largest 10 holders included ARIEL INVESTMENTS, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Institutional Trust Company, N.A., Stonepine Capital Management, LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, NEW YORK STATE COMMON RETIREMENT FUND, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, and BARD ASSOCIATES INC. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
41
Q3 2016 holders
38
Holder diff
-3
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .